Rossari Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 22-06-2024
- Paid Up Capital ₹ 0.71 M
as on 22-06-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 69.08 Cr
as on 22-06-2024
- Revenue -87.37%
(FY 2023)
- Profit -90.48%
(FY 2023)
- Ebitda -75.80%
(FY 2023)
- Net Worth 4.88%
(FY 2023)
- Total Assets 5.70%
(FY 2023)
About Rossari Biotech (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.71 M.
The company has closed loans amounting to ₹69.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Edward Menezes, Ashok Chouhan, and Sunil Chari serve as directors at the Company.
- CIN/LLPIN
U24100MH1997PTC105584
- Company No.
105584
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Rossari Biotech (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Edward Menezes  | Director | 31-Jan-1997 | Current |
| Ashok Chouhan | Director | 19-Oct-2022 | Current |
| Sunil Chari | Director | 31-Jan-1997 | Current |
Financial Performance and Corporate Structure Insights of Rossari Biotech (India).
Rossari Biotech (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 87.37% decrease. The company also saw a substantial fall in profitability, with a 90.48% decrease in profit. The company's net worth moved up by a moderate rise of 4.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rossari Biotech (India)?
In 2023, Rossari Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Romakk Chemicals Private LimitedActive 3 years 9 monthsEdward Menezes and Sunil Chari are mutual person
Buzil Rossari Private LimitedActive 10 years 11 monthsEdward Menezes and Sunil Chari are mutual person
Unitop Chemicals Private LimitedActive 44 years 4 monthsEdward Menezes and Sunil Chari are mutual person
Tristar Intermediates Private LimitedActive 27 years 3 monthsEdward Menezes and Sunil Chari are mutual person
- Rossari Consumer Products Private LimitedActive 25 years 3 months
Edward Menezes and Sunil Chari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Dec 2009 | ₹24.35 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 30 Jun 2006 | ₹6.94 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 24 Apr 2006 | ₹2.00 M | Satisfied |
How Many Employees Work at Rossari Biotech (India)?
Unlock and access historical data on people associated with Rossari Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rossari Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rossari Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
